2020, December 12-13: Head and Neck Pathology Top to Bottom Training to Avoid the Ups and Downs
December 12-13, 2020 - Palm Springs, California
14 CME / 14 SAMs
Head and neck pathology represents a significant portion of surgical pathology practice. Studies have shown this area to be particularly treacherous to community pathologists with up to 53% of diagnoses changed (including 7% with major changes) upon second review at tertiary care hospitals (Kronz and Westra, Curr Opin Otolaryngol Head Neck Surgery 2005; 13:81-4). In recent years there have been numerous developments in head and neck pathology, further complicating this inherent difficulty. Novel entities have been described, pathognomonic molecular alterations have been uncovered, and major shifts in diagnostic classification schemes have been proposed. Many of these concepts were incorporated into the newest editions of the WHO Classifications for Head and Neck and Endocrine Tumors, both of which were published recently.
Taken together, it is difficult for pathologists to stay current and maintain proficiency in head and neck pathology without supplemental training and education. This course is a terrific opportunity to refine your diagnostic skills in a uniquely personal mentoring environment with energetic pathologists whose keen eyes, diagnostic acumen, and a modern approach will create an indelible impression.
This course is designed for general pathologists, practicing surgical pathologists, senior residents and pathologists with special interest in head and neck pathology.
- Recognize the updated WHO terminology of salivary gland carcinoma
- Develop a diagnostic approach to the encapsulated follicular-patterned thyroid nodule
- Describe the algorithmic approach to HPV testing in a head and neck cancer
- Develop a diagnostic approach to the “small round blue cell” sinonasal tumor
- Recognize the appropriate differential diagnosis for sinonasal glandular proliferations
- Justin Bishop, MD
University of Texas Southwestern Medical Center
- James S. Lewis, Jr., MD
- Lisa Rooper, MD
The Johns Hopkins University School of Medicine
- Lester D.R. Thompson, MD (@HeadandNeckPath)
Southern California Permanente Medical Group
CONTINUING MEDICAL EDUCATION AND CONTINUING CERTIFICATION
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this live activity for a maximum of 14 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) and Lifelong Learning (Part II) credit for the purpose of meeting the ABPath requirements for Continuing Certification (CC).
Physicians can earn a maximum of 14 SAM/Part II credit hours.
USCAP records courses at the Interactive Learning Center for future educational purposes. By registering for this course, you consent that your likeness may be used by USCAP.
In the context of the pandemic crisis, USCAP is indefinitely suspending its cancellation policy on all scheduled and upcoming courses until there is a resolution or return to normalcy. However, we encourage you to register (without penalty) for advertised courses (months ahead) in anticipation of return to face-to-face conferences. You can secure your position in advance and cancel, if necessary, with full refund.
The Academy is not responsible for travel expenses incurred as a result of an event cancellation.